3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Premature Birth
1
Patient Compliance
1
Neoplasms
1
Hirschsprung Disease
1
Heart Defects, Congenital
1
Congenital Abnormalities
1
Child Nutrition Disorders
1
Burnout, Psychological
1
Burnout, Professional
1
Acquired Immunodeficiency Syndrome
1
Interventions
Specimen Handling
613
pembrolizumab
583
Magnetic Resonance Spectroscopy
543
Carboplatin
430
Cyclophosphamide
380
Cisplatin
377
Biopsy
366
Paclitaxel
314
Nivolumab
312
Gemcitabine
308
Radiotherapy
268
Bevacizumab
230
Dexamethasone
217
fludarabine
205
Docetaxel
190
durvalumab
188
venetoclax
187
Oxaliplatin
187
Rituximab
174
Fluorouracil
174
atezolizumab
169
Pemetrexed
166
Capecitabine
162
Radiosurgery
160
Doxorubicin
160
Radiation
156
Ipilimumab
144
Lenalidomide
140
Leucovorin
138
Etoposide
134
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Self Care
×
90 days
×
Clear all
NCT04150120
2026-04-06
eChildHealth
Lund University
Phase NA
Completed
720 enrolled
NCT07459868
2026-03-11
CARE-ONC
Fundacion Arturo Lopez Perez
Phase NA
Not yet recruiting
9 enrolled